Literature DB >> 2226060

Detrusor-external sphincter dyssynergia.

M B Chancellor1, S A Kaplan, J G Blaivas.   

Abstract

Detrusor-external sphincter dyssynergia (DESD) is characterized by involuntary contractions of the external urethral sphincter during an involuntary detrusor contraction. It is caused by neurological lesions between the brainstem (pontine micturition centre) and the sacral spinal cord (sacral micturition centre). These include traumatic spinal cord injury, multiple sclerosis, myelodysplasia and other forms of transverse myelitis. There are three main types of DESD. In Type 1 there is a concomitant increase in both detrusor pressure and sphincter EMG activity. At the peak of the detrusor contraction the sphincter suddenly relaxes and unobstructed voiding occurs. Type 2 DESD is characterized by sporadic contractions of the external urethral sphincter throughout the detrusor contraction. In Type 3 DESD there is a crescendo-decrescendo pattern of sphincter contraction which results in urethral obstruction throughout the entire detrusor contraction. In patients with sufficient manual dexterity the most reasonable treatment option is to abolish the involuntary detrusor contractions (to ensure continence) and then to institute intermittent self-catheterization (in order to empty the bladder). The bladder may be paralysed pharmacologically or may be surgically converted to a low pressure urinary reservoir by the technique of augmentation enterocystoplasty. In quadriplegic men, transurethral external sphincterotomy may be performed and the incontinence managed with an external urinary appliance. Without proper treatment over 50% of men with DESD develop serious urological complications within about five years. In women these complications are much less common.

Entities:  

Mesh:

Year:  1990        PMID: 2226060

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  8 in total

1.  The Value of Urodynamics in an Academic Specialty Referral Practice.

Authors:  Anne M Suskind; Lindsey Cox; J Quentin Clemens; Ann Oldendorf; John T Stoffel; Bahaa Malaeb; Yongmei Qin; Anne P Cameron
Journal:  Urology       Date:  2017-04-10       Impact factor: 2.649

Review 2.  The Translational Role of Animal Models for Estrogen-Related Functional Bladder Outlet Obstruction and Prostatic Inflammation.

Authors:  Risto Santti; Emrah Yatkin; Jenni Bernoulli; Tomi Streng
Journal:  Vet Sci       Date:  2022-01-31

3.  Introduction of a urodynamic score to detect pre- and postoperative neurological deficits in children with a primary tethered cord.

Authors:  Blaise Julien Meyrat; Stéphan Tercier; Nicolas Lutz; Bénédict Rilliet; Margarita Forcada-Guex; Olivier Vernet
Journal:  Childs Nerv Syst       Date:  2003-10-14       Impact factor: 1.475

4.  Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis.

Authors:  C D Betts; M T D'Mellow; C J Fowler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

Review 5.  Use of botulinum toxin for voiding dysfunction.

Authors:  David Eldred-Evans; Prokar Dasgupta
Journal:  Transl Androl Urol       Date:  2017-04

Review 6.  Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2018-06-26       Impact factor: 4.546

Review 7.  Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action.

Authors:  Jia-Fong Jhang; Hann-Chorng Kuo
Journal:  Toxins (Basel)       Date:  2016-04-21       Impact factor: 4.546

Review 8.  Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders.

Authors:  Yu-Hua Lin; Bing-Juin Chiang; Chun-Hou Liao
Journal:  Toxins (Basel)       Date:  2020-02-18       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.